Home » Topics » BioWorld Science

BioWorld Science
RSS

Seed funding at Opus Genetics supports progression of programs in Leber congenital amaurosis

Sep. 23, 2021

MDL-001 shown to protect mice against COVID-19-mediated weight loss

Sep. 23, 2021

AbCellera and Everest Medicines collaborate to discover therapeutic antibodies

Sep. 23, 2021

Rosalind Franklin University and Aptinyx collaborate on therapeutics for brain and CNS disorders

Sep. 23, 2021

Hexagon Bio raises funds to advance preclinical pipeline in oncology and infectious diseases

Sep. 23, 2021

BiVictriX completes two antibody discovery campaigns in support of BVX-001

Sep. 23, 2021

OncoNano expands research collaboration with UTSW on novel cancer therapeutics

Sep. 23, 2021

Characterization of potent and selective inhibitors of BET BD2

Sep. 23, 2021

NanoViricides reports preclinical data on NV-CoV-2-R

Sep. 23, 2021

Preclinical evaluation of novel mAChR subtype-selective M1 PAMs

Sep. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...